# A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19

> **NCT05305547** · PHASE3 · COMPLETED · sponsor: **Shionogi** · enrollment: 2093 (actual)

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **DRUG:** S-217622
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05305547
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-03
- **Primary completion:** 2024-01-07
- **Final completion:** 2024-05-24
- **Target enrollment:** 2093 (ACTUAL)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305547, "A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05305547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*